opposing effects polyglutamine expansion native protein complexes contribute sca1 
spinocerebellar ataxia type sca1 dominantly inherited neurodegenerative disease caused expansion glutamine-encoding repeat ataxin atxn1 known polyglutamine diseases glutamine expansion confers toxic functions onto protein however mechanism occurs remains enigmatic light fact mutant protein apparently maintains interactions usual partners show expanded polyglutamine tract differentially affects function host protein context different endogenous protein complexes polyglutamine expansion atxn1 favours formation particular protein complex containing rbm17 contributing sca1 neuropathology means gain-of-function mechanism concomitantly polyglutamine expansion attenuates formation function another protein complex containing atxn1 capicua contributing sca1 partial loss-of-function mechanism model provides mechanistic insight molecular pathogenesis sca1 well polyglutamine diseases 
